Group pushing for generic version of remdesivir drug to treat Covid-19 patients

  • Nation
  • Tuesday, 19 May 2020

Gilead Sciences Inc pharmaceutical company - Filepic

KUALA LUMPUR: A group of more than 50 health-related organisations and individuals is urging American biopharmaceutical company Gilead Sciences to allow Malaysia to import generic versions of remdesivir, an anti-viral drug used to treat Covid-19 patients.

The generic versions of remdesivir, which was originally developed to treat Ebola, are from manufacturers Gilead has given voluntary licensing (VL) agreements to.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Nation

Penang building collapse: One confirmed dead, two others injured
The logging activities in Sipitang are legal, says Sabah Forestry Dept
Sarawak contributed greatly in ensuring nation's political stability, says Anwar
Muslim countries must work together to spur their development, says Anwar
Nine workers feared dead after building collapse in Penang
I was just responding to Aman Palestin, Azam tells lawyer
Anwar, Indonesian vice-president to deliver keynote address at GMBF 2023
Underage marriages: 533 couples recorded in Kelantan since 2019
Perak MB to present state Budget this Friday
Posting of auxiliary police has not reached 50%, says Bukit Aman

Others Also Read